Innovations In: RSV

RSV is the leading cause of infant hospitalizations in the U.S. But that could soon change as research advances lead to new preventive drugs for everyone

Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization

Immunologist Zachary Rubin explains how, according to a recent study, living through a pandemic might accelerate brain aging.

Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu vaccines.

Should you take vitamin C or zinc when you are sick with a common cold or influenza? Immunologist Zachary Rubin explains which at-home remedies actually help.

Respiratory syncytial virus (RSV) can be life-threatening, but there are new treatments to prevent and treat the disease.

The journey toward an RSV vaccine for children has been wrought with tragedy and setbacks. But six decades after scientists embarked on that path, they are nearing the finish line

Abigail Echo-Hawk, a preeminent Native American public health expert, discusses RSV, “data genocide” and positive change driven by Indigenous storytelling

Respiratory syncytial virus (RSV) continues to affect infants and older and immunocompromised people around the world. These graphics reveal where the burden lies and what the effects of immunizations are

American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a breakthrough immunization is helping to close the gap

The year 2023 marked the debut of groundbreaking innovations to prevent severe RSV infections in infants. Now protected babies are way less likely to develop severe infections or to end up in the ICU